Prevention of onychomycosis reinfection for patients with complete cure of all 10 toenails: Results of a double-blind, placebo-controlled, pilot study of prophylactic miconazole powder 2%

Erin M. Warshaw, Katherine R. St Clair

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Abstract

The objective of this 2-year, double-blind, placebo-controlled, randomized trial involving 48 participants was to determine if biweekly miconazole powder prevents onychomycosis recurrence. Intent-to-treat analysis found no significant differences in mycologic, clinical, or complete onychomycosis reinfection rates or time to reinfection. Limitations include small sample size and dosing regimen.

Original languageEnglish (US)
Pages (from-to)717-720
Number of pages4
JournalJournal of the American Academy of Dermatology
Volume53
Issue number4
DOIs
StatePublished - Oct 2005

Bibliographical note

Funding Information:
Funding source: Coloplast Corp, Skin Health Division, through a generous, unrestricted research grant. Dr Warshaw's career has been supported by a VA Cooperative Studies Clinical Research Career Development Grant.

Fingerprint

Dive into the research topics of 'Prevention of onychomycosis reinfection for patients with complete cure of all 10 toenails: Results of a double-blind, placebo-controlled, pilot study of prophylactic miconazole powder 2%'. Together they form a unique fingerprint.

Cite this